Acellular Pertussis Vaccine Safety and Efficacy in Children, Adolescents and Adults

Author： Casey Janet R.   Pichichero Michael E.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.10, 2005-01, pp. : 1367-1389

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acellular pertussis vaccine protects adolescents, adults

By  

Inpharma, Vol. 1, Iss. 1510, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Economic Evaluation of an Extended Acellular Pertussis Vaccine Program for Adolescents in Québec, Canada

By Iskedjian Michael  

Pediatric Drugs, Vol. 7, Iss. 2, 2005-01 ,pp. : 123-136

Adis International

Access to resources Recommend Favorite

Spotlight on Tdap 5 Vaccine (Covaxis®) as a Single-Booster Immunization for the Prevention of Tetanus, Diphtheria, and Pertussis: In Children (Aged ≥4 Years), Adolescents, and Adults†

By Scott Lesley J.  

Pediatric Drugs, Vol. 13, Iss. 2, 2011-04 ,pp. : 133-135

Adis International

Access to resources Recommend Favorite

Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada

By Iskedjian M.   Einarson T.R.  

PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. : 551-563

Adis International

Access to resources Recommend Favorite

New acellular pertussis vaccine superior in Ontario, Canada

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 319, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite